Halozyme Therapeutics
HALO
#2108
Rank
$5.96 B
Marketcap
$43.22
Share price
-0.25%
Change (1 day)
6.87%
Change (1 year)

Market capitalization of Halozyme Therapeutics (HALO)

Market cap: $5.96 Billion

As of August 2022 Halozyme Therapeutics has a market cap of $5.96 Billion. This makes Halozyme Therapeutics the world's 2108th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Halozyme Therapeutics from 2004 to 2022

End of year Market Cap

Year Market cap Change
2022$5.96 B5.32%
2021$5.66 B-1.95%
2020$5.77 B138.2%
2019$2.42 B14.48%
2018$2.11 B-26.59%
2017$2.88 B125.44%
2016$1.27 B-42.39%
2015$2.22 B83.06%
2014$1.21 B-29.34%
2013$1.71 B127.01%
2012$0.75 B-23.31%
2011$0.98 B23.79%
2010$0.79 B48.02%
2009$0.53 B18%
2008$0.45 B-17.66%
2007$0.55 B0.1%
2006$0.55 B404.64%
2005$0.10 B1.3%
2004$0.10 B

End of Day market cap according to different sources

On Aug 9th, 2022 the market cap of Halozyme Therapeutics was reported to be:

$6.10 Billion
by Yahoo Finance
$5.97 Billion
by CompaniesMarketCap
$5.97 Billion
by Nasdaq
$5.97 Billion
by Iex Cloud
$6.21 Billion
by Reuters

Market capitalization for similar companies or competitors

Name Market cap Market cap differencediff. Country
$447.01 B 7,397.46%๐Ÿ‡บ๐Ÿ‡ธ USA
$277.57 B 4,555.52%๐Ÿ‡บ๐Ÿ‡ธ USA
$288.65 B 4,741.40%๐Ÿ‡บ๐Ÿ‡ธ USA
$111.16 B 1,764.48%๐Ÿ‡ซ๐Ÿ‡ท France
$30.19 B 406.47%๐Ÿ‡บ๐Ÿ‡ธ USA
$1.04 B-82.44%๐Ÿ‡บ๐Ÿ‡ธ USA